Read our insights and commentary about pharmaceutical industry news and healthcare innovation globally. Subscribe to our monthly newsletter to keep up to date with our thought leadership, news, and updates.
Showing 5 of 116 posts
November 3, 2020 | Blog
New cell therapy technologies show blockbuster potential for improved accessibility and efficacy in a wide range of indications, though these therapies come with their own downfalls that healthcare systems will need to adapt to in order for these products to reach their full potential.
November 3, 2020 | Infographics
Digital Therapies for Opioid Use Disorder (OUD) have been assessed by ICER to determine whether they are effective, both in terms of cost, and improvement in retention in treatment.
October 29, 2020 | Blog
An analysis of the key drug pricing proposals in the 2020 USA Election in terms of political focus, party priorities, implementation feasibility, and potential risk to biopharma.
October 20, 2020 | Blog
Pharma and biotech companies should be prepared to make long-term investments in capability building, market development, and evidence generation to maximize the value of digital companions.